Florian Bea
Impact in
- Clinical Biochemistry top 1%
- Advanced Glycation End Products research
- Immunology top 5%
- Atherosclerosis and Cardiovascular Diseases
- Psoriasis: Treatment and Pathogenesis
Papers in
-
- Angiogenesis and VEGF in Cancer 2
- Surgery 7
- Coronary Interventions and Diagnostics 3
- Lipoproteins and Cardiovascular Health 3
- Co-authors
- Hugo A. Katus (25 shared papers)Erwin Blessing (25 shared papers)Michael E. Rosenfeld (16 shared papers)Michael R. Preusch (19 shared papers)Thomas J. Dengler (4 shared papers)Christian Erbel (4 shared papers)Felix Lasitschka (3 shared papers)Dittmar Böckler (2 shared papers)
- Journals
- Arteriosclerosis Thrombosis and Vascular Biology (5 papers)Basic Research in Cardiology (4 papers)Circulation (4 papers)Atherosclerosis (4 papers)Drug Design Development and Therapy (3 papers)
- Partner nations
- GermanyUnited StatesChina
In The Last Decade
Florian Bea
45 papers receiving 2.9k citations
Florian Bea's Hit Papers
Peers
Comparison fields: 5 of 100
- Clinical Biochemistry 329
- Immunology 805
- Internal Medicine 73
- Cardiology and Cardiovascular Medicine 453
- Hematology 197
Countries citing papers authored by Florian Bea
This map shows the geographic impact of Florian Bea's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Florian Bea with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Florian Bea more than expected).
Fields of papers citing papers by Florian Bea
This network shows the impact of papers produced by Florian Bea. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Florian Bea. The network helps show where Florian Bea may publish in the future.
Co-authors
The 25 scholars most cited alongside Florian Bea, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 45 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | High-Mobility Group Box-1 in Ischemia-Reperfusion Injury of the Heart Hit paper breakdown → | 2008 | 534 |
| 2 | 2009 | 290 | |
| 3 | 2009 | 178 | |
| 4 | 2010 | 151 | |
| 5 | 2005 | 140 | |
| 6 | 2002 | 128 | |
| 7 | 2014 | 116 | |
| 8 | 2011 | 100 | |
| 9 | 2009 | 94 | |
| 10 | 2003 | 89 | |
| 11 | 2002 | 87 | |
| 12 | 2006 | 85 | |
| 13 | 2010 | 61 | |
| 14 | 2008 | 61 | |
| 15 | 2007 | 61 | |
| 16 | 2009 | 60 | |
| 17 | 2003 | 58 | |
| 18 | 2007 | 57 | |
| 19 | 2003 | 52 | |
| 20 | 2011 | 47 |
About Florian Bea
Florian Bea is a scholar working on Molecular Biology, Surgery, Immunology, Cardiology and Cardiovascular Medicine and Rheumatology, having authored 45 papers that have together received 2.9k indexed citations. Recurring topics across this work include Atherosclerosis and Cardiovascular Diseases (6 papers), Coronary Interventions and Diagnostics (3 papers), Lipoproteins and Cardiovascular Health (3 papers), GDF15 and Related Biomarkers (3 papers), Advanced Glycation End Products research (2 papers), Protease and Inhibitor Mechanisms (2 papers), Angiogenesis and VEGF in Cancer (2 papers) and NF-κB Signaling Pathways (2 papers). The work is most often cited by research in Clinical Biochemistry (329 citations), Immunology (805 citations), Internal Medicine (73 citations), Cardiology and Cardiovascular Medicine (453 citations) and Hematology (197 citations). Florian Bea has collaborated with scholars based in Germany, United States and China. Frequent co-authors include Hugo A. Katus, Erwin Blessing, Michael E. Rosenfeld, Michael R. Preusch, Thomas J. Dengler, Christian Erbel, Felix Lasitschka, Dittmar Böckler, Susanne Wangler and Sebastian J. Buss. Their work appears in journals such as Arteriosclerosis Thrombosis and Vascular Biology, Basic Research in Cardiology, Circulation, Atherosclerosis and Drug Design Development and Therapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.